Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, and Leukocyte rich PRF), By Origin (Autologous, Allogenic, and Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024

Code : CMI936

Pages :184

Formats :

Excel and PDF

Industry : Biotechnology

Market Challenges – Uncertainty in Efficacy of Platelet Rich Plasma Therapies and Lack of Standardization

Increasing recommendations by government bodies against the use of PRP is expected to hinder the market growth. For instance, in January 2020, the American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee, which did not recommend the use of PRP injections for treatment of hip and knee osteoarthritis. Lack of standardization in the preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering the market growth. Lack of standardization has led to the lack of strong evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.

Market Opportunities – Increasing Research and Development Activities by Key Market Players

Increasing research and development activities for PRP by key market players, in order to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in June 2022, a research article published in the Journal of Skin and Steam Cells, where researchers found that under sterile conditions, platelet rich plasma preparation and administration protocol reduced the prevalence of further contamination and complications associated with it. The occurrence of infection after injection was zero, even in patients with hemophilia. When carried out under controlled circumstances, platelet rich plasma therapy is effective for treating a wide range of etiologies and involves both intra-articular and soft tissue operations with no danger of infection.